Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
World Cup
Social Media
Elon Musk
Donald Trump
Artificial Intelligence
Natural Disasters
Soccer
Cricket
Drones
Instagram
Real Madrid
medwirenews.com image

News from medwirenews.com

We’ve assigned a media bias rating of unknown to medwirenews.com. You can read more about our methodology here.

Information about medwirenews.com

Where is medwirenews.com located?medwirenews.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top medwirenews.com News

Childhood cancer survivors might benefit from cochlear implants
Suresnes · Suresnes

Childhood cancer survivors might benefit from cochlear implants

By Lynda Williams, medwireNews ReportermedwireNews: Childhood cancer survivors with severe to profound sensorineural hearing loss following chemotherapy or radiotherapy may be candidates for cochlear implants, US researchers believe.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © Sladic / Getty Images / iStock The post…Read Article

Polygenic risk score may improve prostate cancer screening

medwireNews: A polygenic risk score could help direct prostate cancer screening towards those at highest risk for the disease, the BARCODE1 investigators report.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © angellodeco / stock.adobe.com The post Polygenic risk score may improve prostate cancer screening appeared firs…Suresnes · SuresnesRead Article

Intensive systolic blood pressure control reduces CVD mortality risk in the over 80s

By Lucy Piper, medwireNews ReportermedwireNews: Antihypertensive treatment of patients over the age of 80 years to a target systolic blood pressure below 130 mmHg could significantly reduce their risk of death from cardiovascular disease by 26%, suggests an analysis of NHANES data.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage …Suresnes · SuresnesRead Article

Half-dose apixaban noninferior for preventing recurrent VTE in cancer patients

By Lynda Williams, medwireNews ReportermedwireNews: For patients with active cancer and venous thromboembolism, a reduced dose of apixaban is noninferior to the standard dose for preventing recurrent thromboembolic episodes and significantly reduces the risk of clinically relevant bleeding, report the API-CAT investigators.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full st…Cancer · SuresnesRead Article

‘Accelerated’ onset of aging-related disease highlighted for childhood cancer survivors

By Lynda Williams, medwireNews ReportermedwireNews: Children who survive for at least 5 years after treatment for cancer are 2.7 times more likely to develop one of eight aging-related chronic health conditions before the age of 65 years than members of the general population, US researchers suggest.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Se…CancerSee the Story

Mixed results for tetramethylpyrazine nitrone treatment in ALS

By Lucy Piper, medwireNews ReportermedwireNews: Tetramethylpyrazine nitrone does not slow overall functional decline in patients with amyotrophic lateral sclerosis, but it may help retain grip strength and is well tolerated, suggest study findings.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © JuanCi Studio / stock.ad…Suresnes · SuresnesRead Article

Vaccine may improve breast cancer treatment outcomes

100% Center coverage: 1 sources
Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study. The study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and positive …CancerSee the Story

Off-the-Shelf CAR T-Cell Therapy P-BCMA-ALLO1 Is Efficacious in Relapsed/Refractory Multiple Myeloma

P-BCMA-ALLO1 displayed high response rates and compelling safety in a heavily pretreated population of patients with relapsed/refractory multiple myeloma.CancerSee the Story

Cancer-related PE death increase shown in the USA

By Lynda Williams, medwireNews ReportermedwireNews: US study findings indicate that the incidence of pulmonary embolism-related death in people with cancer rose significantly between 2011 and 2020 despite an overall reduction in age-adjusted cancer diagnoses and cancer-related deaths over the period.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Se…Cancer · United StatesRead Article

Breaking News Topics Related to medwirenews.com

Suresnes

Suresnes

Tlaxcala

Tlaxcala

Hauts-De-Seine

Hauts-De-Seine

France

France

Île-De-France

Île-De-France

Cancer

Cancer

News
For You
SearchBlindspotLocal